ConductScience.org, home

Paper33544313

Regression of portal hypertension: underlying mechanisms and therapeutic strategies.

Selicean S and 5 others. Hepatol Int, 2021. Cited by 35 papers, by iCite.

Cite this record

ConductScience Library. Regression of portal hypertension: underlying mechanisms and therapeutic strategies. Papers, record 33544313. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33544313

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Regression of portal hypertension: underlying mechanisms and therapeutic strategies.
PubMed
Journal
Hepatol Int
PubMed
Year
2021
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
35
iCite
Relative citation ratio, by iCite
2.24
iCite
Revised in PubMed
2024-03-30
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Selicean SSonia
2Wang CCong
3Guixé-Muntet SSergi
4Stefanescu HHoria
5Kawada NNorifumi
6Gracia-Sancho JJordihttps://orcid.org/0000-0001-7736-4089

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hypertension, PortalMajor topic
Esophageal and Gastric Varices
Gastrointestinal Hemorrhage
Humans
Liver Cirrhosis
Microcirculation

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT06097715Clinical,Endoscopic and Radiological Assessment of Portal Hypertension in Children With Chronic Liver DiseasesBackground

Source ClinicalTrials.gov

Download CSV of trials

References132

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128734831Effects of All-Oral Anti-Viral Therapy on HVPG and Systemic Hemodynamics in Patients With Hepatitis C Virus-Associated Cirrhosis.Gastroenterology2017https://conductscience.org/library/papers/28734831PubMed
222032637The effects of sorafenib on the portal hypertensive syndrome in patients with liver cirrhosis and hepatocellular carcinoma--a pilot study.Aliment Pharmacol Ther2012https://conductscience.org/library/papers/22032637PubMed
323216382Long-term administration of rifaximin improves the prognosis of patients with decompensated alcoholic cirrhosis.J Gastroenterol Hepatol2013https://conductscience.org/library/papers/23216382PubMed
427634134Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients.Liver Int2016https://conductscience.org/library/papers/27634134PubMed
519157625Angiogenesis in liver disease.J Hepatol2009https://conductscience.org/library/papers/19157625PubMed
633128017Molecular and cellular mechanisms of liver fibrosis and its regression.Nat Rev Gastroenterol Hepatol2021https://conductscience.org/library/papers/33128017PubMed
712500206Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement.Hepatology2003https://conductscience.org/library/papers/12500206PubMed
828960366Portal pressure and liver stiffness measurements in the prediction of fibrosis regression after sustained virological response in recurrent hepatitis C.Hepatology2018https://conductscience.org/library/papers/28960366PubMed
922365955Comparison of endothelin receptors in normal versus cirrhotic human liver and in the liver from endothelial cell-specific ETB knockout mice.Life Sci2012https://conductscience.org/library/papers/22365955PubMed
1020800926Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: new targets for the treatment of portal hypertension?J Hepatol2010https://conductscience.org/library/papers/20800926PubMed
1132164767A phase 2 randomised controlled trial of serelaxin to lower portal pressure in cirrhosis (STOPP).Trials2020https://conductscience.org/library/papers/32164767PubMed
1232535060Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension.J Hepatol2020https://conductscience.org/library/papers/32535060PubMed
1330765123Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study.Lancet2019https://conductscience.org/library/papers/30765123PubMed
1427941216Aging enhances liver fibrotic response in mice through hampering extracellular matrix remodeling.Aging (Albany NY)2016https://conductscience.org/library/papers/27941216PubMed
1516393289Effect of vardenafil, an inhibitor of phosphodiesterase-5, on portal haemodynamics in normal and cirrhotic liver -- results of a pilot study.Aliment Pharmacol Ther2006https://conductscience.org/library/papers/16393289PubMed
1629922768Liver stiffness better predicts portal hypertension after HCV eradication.J Gastrointestin Liver Dis2018https://conductscience.org/library/papers/29922768PubMed
1724764791Reversibility of liver fibrosis.Gastroenterol Hepatol (N Y)2013https://conductscience.org/library/papers/24764791PubMed
1822271347A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis.Hepatology2012https://conductscience.org/library/papers/22271347PubMed
1923601333Effects of the adjunctive probiotic VSL#3 on portal haemodynamics in patients with cirrhosis and large varices: a randomized trial.Liver Int2013https://conductscience.org/library/papers/23601333PubMed
2012475903
Mutation in collagen-1 that confers resistance to the action of collagenase results in failure of recovery from CCl4-induced liver fibrosis, persistence of activated hepatic stellate cells, and diminished hepatocyte regeneration.
FASEB J2003https://conductscience.org/library/papers/12475903PubMed

See all 132 referencesDownload CSV of references

Cited by29

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.

PMIDTitleJournalYearIn PapersSource
42753189Cirrhosis Impairs Reconstitution of the Circulating T-Lymphocyte Compartment After Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection.United European Gastroenterol J2026https://conductscience.org/library/papers/42753189PubMed
42519788Imaging-based fibrosis assessment and risk stratification in MASLD.Front Med (Lausanne)2026https://conductscience.org/library/papers/42519788PubMed
42416937Diagnostic Accuracy of Liver and Spleen Elastography for Detecting Portal Hypertension Defined by Hepatic Venous Pressure Gradient (HVPG) in Chronic Liver Disease: A Systematic Review.Cureus2026https://conductscience.org/library/papers/42416937PubMed
41921416Single-cell fixed RNA profiling uncovers SEMA4D and LMCD1 as therapeutic targets in a liver fibrosis model.JHEP Rep2026https://conductscience.org/library/papers/41921416PubMed
41897531Cytoglobin in Hepatic Stellate Cells Plays Anti-Fibrotic Role in Chronic Liver Injury.Antioxidants (Basel)2026https://conductscience.org/library/papers/41897531PubMed
41811796Recompensation of Liver Cirrhosis: Definition, Mechanism, Etiological Differences, Prognosis, and Challenges.Can J Gastroenterol Hepatol2026https://conductscience.org/library/papers/41811796PubMed
41669926Indocyanine Green Retention Rate at 15 Minutes as a Key Predictor of Clinically Significant Portal Hypertension in Cirrhosis: Development and Validation of a Superior Non-Invasive Diagnostic Model.Turk J Gastroenterol2025https://conductscience.org/library/papers/41669926PubMed
41659769Carvedilol decreases hepatic vascular resistance by reducing fibrogenesis and reversing endothelial dysfunction in cirrhotic rats.JHEP Rep2026https://conductscience.org/library/papers/41659769PubMed
41594255Assessment of Liver Fibrosis Stage and Cirrhosis Regression After Long-Term Follow-Up Following Sustained Virological Response.Diagnostics (Basel)2026https://conductscience.org/library/papers/41594255PubMed
41368107Direct-acting antiviral therapy reduces variceal rebleeding and improves liver function in hepatitis C virus-related cirrhosis: A multicenter retrospective cohort study.World J Hepatol2025https://conductscience.org/library/papers/41368107PubMed
41024757Advances in portal hypertension management: Evolution of the Baveno guidelines.World J Gastroenterol2025https://conductscience.org/library/papers/41024757PubMed
40980160GTX-11 improves portal hypertension, liver fibrosis, and sinusoidal cells phenotype in experimental MASH.JHEP Rep2025https://conductscience.org/library/papers/40980160PubMed
40061591Multicenter analysis on the correlation between the anatomical characteristics of hepatic veins and hepatic venous wedge pressure.World J Gastroenterol2025https://conductscience.org/library/papers/40061591PubMed
39997697From Pathophysiology to Practice: Evolving Pharmacological Therapies, Clinical Complications, and Pharmacogenetic Considerations in Portal Hypertension.Metabolites2025https://conductscience.org/library/papers/39997697PubMed
39870944Preventing the progression of cirrhosis to decompensation and death.Nat Rev Gastroenterol Hepatol2025https://conductscience.org/library/papers/39870944PubMed
39732832Hemodynamic comparisons of different shunt positions and geometrical model simplification strategies in the simulation of transjugular intrahepatic portosystemic shunt (TIPS).Sci Rep2024https://conductscience.org/library/papers/39732832PubMed
39640222Mechanisms and implications of recompensation in cirrhosis.JHEP Rep2024https://conductscience.org/library/papers/39640222PubMed
39282182From Cirrhosis to the Dysbiosis (A Loop of Cure or Complications?).Indian J Microbiol2024https://conductscience.org/library/papers/39282182PubMed
38934697Screening patients in general practice for advanced chronic liver disease using an innovative IT solution: The Liver Toolkit.Hepatol Commun2024https://conductscience.org/library/papers/38934697PubMed
37842727Recent Advances in the Pathogenesis and Clinical Evaluation of Portal Hypertension in Chronic Liver Disease.Gut Liver2024https://conductscience.org/library/papers/37842727PubMed

See all 29 cited byDownload CSV of cited by

Genes21

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ACTA158PubTator's text mininghttps://conductscience.org/library/genes/58NCBI Gene
CCR2729230PubTator's text mininghttps://conductscience.org/library/genes/729230NCBI Gene
CCR51234PubTator's text mininghttps://conductscience.org/library/genes/1234NCBI Gene
CD34947PubTator's text mininghttps://conductscience.org/library/genes/947NCBI Gene
CSF31440PubTator's text mininghttps://conductscience.org/library/genes/1440NCBI Gene
EDN11906PubTator's text mininghttps://conductscience.org/library/genes/1906NCBI Gene
EDNRB1910PubTator's text mininghttps://conductscience.org/library/genes/1910NCBI Gene
GCG2641PubTator's text mininghttps://conductscience.org/library/genes/2641NCBI Gene
GLP1R2740PubTator's text mininghttps://conductscience.org/library/genes/2740NCBI Gene
LEP3952PubTator's text mininghttps://conductscience.org/library/genes/3952NCBI Gene
LGALS33958PubTator's text mininghttps://conductscience.org/library/genes/3958NCBI Gene
LOXL24017PubTator's text mininghttps://conductscience.org/library/genes/4017NCBI Gene
MAP3K54217PubTator's text mininghttps://conductscience.org/library/genes/4217NCBI Gene
NR1H49971PubTator's text mininghttps://conductscience.org/library/genes/9971NCBI Gene
PGF5228PubTator's text mininghttps://conductscience.org/library/genes/5228NCBI Gene
PPARG5468PubTator's text mininghttps://conductscience.org/library/genes/5468NCBI Gene
PROM18842PubTator's text mininghttps://conductscience.org/library/genes/8842NCBI Gene
REN5972PubTator's text mininghttps://conductscience.org/library/genes/5972NCBI Gene
RLN26019PubTator's text mininghttps://conductscience.org/library/genes/6019NCBI Gene
TNF7124PubTator's text mininghttps://conductscience.org/library/genes/7124NCBI Gene

See all 21 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33544313

GET https://conductscience.org/api/papers/v1/33544313/references?page=2